FDA-approved Therapies for Geographic Atrophy

Opinion
Video

An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.

Recent Videos
Video 4 - "Treating Geographic Atrophy in Patients with Concurrent Neovascular AMD"
Video 3 - "Managing a Patient with Bilateral Geographic Atrophy"
Video 1 - "Geographic Atrophy: Overview, Diagnosis, and Progression"
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
Related Content
Ophthalmology researchers develop framework to reduce spin in scientific reporting

Ophthalmology researchers develop framework to reduce spin in scientific reporting

David Hutton
July 22nd 2024
Article
Spotlighting telemedicine in the year of a pandemic

Spotlighting telemedicine in the year of a pandemic

Alex Delaney-Gesing
October 19th 2020
Podcast
Low risk of elevated IOP with lampalizumab for geographic atrophy over 1 year

Low risk of elevated IOP with lampalizumab for geographic atrophy over 1 year

Lynda Charters
July 3rd 2024
Article
Geographic atrophy and future plans: What residents should consider

Geographic atrophy and future plans: What residents should consider

Sydney M Crago
July 2nd 2024
Article
4DMT receives IND clearance for 4D-175 for treatment of geographic atrophy

4DMT receives IND clearance for 4D-175 for treatment of geographic atrophy

Martin David Harp
June 28th 2024
Article
Treatment options for patients with geographic atrophy

Treatment options for patients with geographic atrophy

Lynda Charters
June 21st 2024
Article
© 2024 MJH Life Sciences

All rights reserved.